Ballsy Celgene Continues to Tread Carefully Into Neurosciences Post author:Sam Post published:January 25, 2018 Post category:BioPharma The company made some bold moves this month in acquiring Juno and Impact Source: BioSpace You Might Also Like Is Celgene Considering Going Private? March 14, 2018 AstraZeneca PLC Forges $400 Million Parkinson's R&D Deal With Takeda August 28, 2017 Exelixis Announces Second Quarter 2017 Financial Results And Provides Corporate Update August 2, 2017
Exelixis Announces Second Quarter 2017 Financial Results And Provides Corporate Update August 2, 2017
